{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:14:21Z","timestamp":1769728461074,"version":"3.49.0"},"reference-count":20,"publisher":"Endocrinology Research Centre","issue":"5","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND:<\/jats:bold>\n                    Currently, alternative minimally invasive methods for assessing the steroid profile in patients with congenital adrenal hyperplasia (CAH) are being actively developed. Saliva has proven to be a promising medium in a series of international studies. The use of saliva as an alternative minimally invasive biological material not only reduces the stress associated with venipuncture but also decreases the workload for medical staff, as saliva collection can be performed at home.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>AIM:<\/jats:bold>\n                    <jats:bold\/>\n                    Evaluate the correlation between concentrations of steroid hormones in the blood and saliva in prepubertal and pubertal groups of patients with congenital adrenal hyperplasia using high-performance liquid chromatography with tandem mass spectrometric detection (HPLC-MS\/MS).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MATERIALS AND METHODS:<\/jats:bold>\n                    A prospective intervention study for diagnosing and disease compensation in 45 patients aged 3 to 17 years undergoing a routine inpatient examination with an established diagnosis of CAH (classic 21-hydroxylase deficiency). All children underwent a one-stage laboratory test at the National Medical Research Center of Endocrinology of the Ministry of Health of the Russian Federation in October 2024.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    In the prepubertal group (N=14), a strong positive correlation was found between serum and saliva for the concentration of 17OH-progesterone (p=&lt;0.01; r=0.88), androstenedione (p=&lt;0.001; r=0.84) and dehydroepiandrosterone (p=0.001; r=0.78). In the pubertal group (N=31), a strong positive correlation was found between serum and saliva for the concentrations of 17OH-progesterone (p=&lt;0.01; r=0.94), androstenedione (p=&lt;0.01; r=0.94), testosterone (p=&lt;0.01; r=0.94), and progesterone (p=&lt;0.01; r=0.79), as well as a moderate correlation for 21-deoxycortisol (p=0.003; r=0.52).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    <jats:bold\/>\n                    Most steroids used for diagnosis and monitoring the therapy in patients with CAH have a strong or moderate correlation between serum and saliva.\n                  <\/jats:p>","DOI":"10.14341\/probl13551","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:51:37Z","timestamp":1764838297000},"page":"82-89","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":0,"title":["Salivary steroid profile investigation by high performance liquid chromatography\u2013tandem mass spectrometry in children with congenital adrenal hyperplasia"],"prefix":"10.14341","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8159-8769","authenticated-orcid":true,"given":"M. A.","family":"Tiulpakov","sequence":"first","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-7694","authenticated-orcid":true,"given":"N. Y.","family":"Kalinchenko","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7016-7355","authenticated-orcid":true,"given":"D. V.","family":"Bychenkov","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-1662","authenticated-orcid":true,"given":"V. A.","family":"Ioutsi","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6266-7782","authenticated-orcid":true,"given":"M. A.","family":"Antsupova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-3187","authenticated-orcid":true,"given":"A. R.","family":"Elfimova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6429-7198","authenticated-orcid":true,"given":"E. V.","family":"Nagaeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5458","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Auer MMK, Nordenstr\u00f6m A, Lajic S, et al. Congenital adrenal hyperplasia. The Lancet. 2023;401(10372)\u0436227\u2013244. doi: https:\/\/doi\/org\/10.1016\/S0140-6736(22)01330-7","DOI":"10.1016\/S0140-6736(22)01330-7"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Mokrysheva NG, Melnichenko GA, Adamyan LV, Troshina EA, Molashenko NV, et al. Russian clinical practice guidelines \u00abcongenital adrenal hyperplasia\u00bb. Obesity and metabolism. 2021;18(3):345-382. doi: https:\/\/doi.org\/10.14341\/omet12787","DOI":"10.14341\/omet12787"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Wong T, Shackleton CH, Covey TR, et al. \u00abIdentification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Clin Chem. 1992;38(9):1830-7","DOI":"10.1093\/clinchem\/38.9.1830"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ionova T.A., Kalinchenko N.Yu., Tyulpakov A.N., et al. Comparative analysis of the effectiveness of immunoassay and tandem mass spectrometry methods in retesting children with suspected congenital adrenal cortex dysfunction \/\/ Problems of Endocrinology. 2013. - V. 59. - No. 2. - P. 12-18.","DOI":"10.14341\/probl201359212-18"},{"key":"ref5","unstructured":"Goncharov N.P., Kolesnikova G.S. Biochemical markers of congenital dysfunction of the adrenal cortex and steroidogenesis disorders. \/\/ Problems of Endocrinology. - 2007. - Vol. 53. - No. 1. - P. 30-33. doi: https:\/\/doi.org\/10.14341\/probl200753130-33"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Claahsen-van der Grinten, Hedi L, et al. Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management. Endocrine reviews. 2022;43(1):91-159. doi: https:\/\/doi.org\/10.1210\/endrev\/bnab016","DOI":"10.1210\/endrev\/bnab016"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"de Hora M, Heather N, Webster D, Albert B, Hofman P. The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives. Front Endocrinol (Lausanne). 2023;14:1226284. doi: https:\/\/doi.org\/10.3389\/fendo.2023.1226284","DOI":"10.3389\/fendo.2023.1226284"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wudy SA, Schuler G, S\u00e1nchez-Guijo A, Hartmann MF. The art of measuring steroids: Principles and practice of current hormonal steroid analysis. J Steroid Biochem Mol Biol. 2018;179:88-103. doi: https:\/\/doi.org\/10.1016\/j.jsbmb.2017.09.003","DOI":"10.1016\/j.jsbmb.2017.09.003"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Abawi O, Sommer G, Groessl M, Halbsguth U, Hannema SE, et al. THU208 Predicting Treatment Quality Assessment Of Children With Congenital Adrenal Hyperplasia Using 24h Urine Metabolomics Profiling And A Machine Learningassisted Approach. J Endocr Soc. 2023;7(Suppl 1):bvad114.1459. doi: https:\/\/doi.org\/10.1210\/jendso\/bvad114.1459","DOI":"10.1210\/jendso\/bvad114.1459"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Nowotny HF, Auer MK, Lottspeich C, Schmidt H, Dubinski I, et al. Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2021;106(11):e4509-e4519. doi: https:\/\/doi.org\/10.1210\/clinem\/dgab446","DOI":"10.1210\/clinem\/dgab446"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kamrath C, Hartmann MF, Pons-K\u00fchnemann J, Wudy SA. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia. Metabolism. 2020;112:154354. doi: https:\/\/doi.org\/10.1016\/j.metabol.2020.154354","DOI":"10.1016\/j.metabol.2020.154354"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bacila IA, Lawrence NR, Badrinath SG, Balagamage C, Krone NP. Biomarkers in congenital adrenal hyperplasia. Clin Endocrinol (Oxf ). 2024;101(4):300-310. doi: https:\/\/doi.org\/10.1111\/cen.14960","DOI":"10.1111\/cen.14960"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bacila I, Adaway J, Hawley J, Mahdi S, Krone R, et al. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2019;104(12):6417-6429. doi: https:\/\/doi.org\/10.1210\/jc.2019-00031","DOI":"10.1210\/jc.2019-00031"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Adriaansen BPH, Kamphuis JS, Schr\u00f6der MAM, et al. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf ). 2022;97(1):36-42. doi: https:\/\/doi.org\/10.1111\/cen.14690","DOI":"10.1111\/cen.14690"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Dubinski I, Bechtold S, Bidlingmaier M, Reisch N, Schmidt H. Salivary 17-Hydroxyprogesterone Levels in Children with Congenital Adrenal Hyperplasia: A Retrospective Longitudinal Study Considering Auxological Parameters. Horm Res Paediatr. 2023;96(3):259-266. doi: https:\/\/doi.org\/10.1159\/000526485","DOI":"10.1159\/000526485"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Merke DP, Mallappa A, Arlt W, Brac de la Perriere A, et al. J Clin Endocrinol Metab. 2021;106(5):e2063-e2077. doi: https:\/\/doi.org\/10.1210\/clinem\/dgab051","DOI":"10.1210\/clinem\/dgab051"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Tyulpakov M.A., Nagaeva E.V., Kalinchenko N.Yu., et al. Evaluation of the steroid profile in saliva in patients with congenital dysfunction of the adrenal cortex. \/\/ Problems of Endocrinology. - 2024. - V. 69. - No. 6. doi: https:\/\/doi.org\/10.14341\/probl13328-10593","DOI":"10.14341\/probl13328"},{"key":"ref18","unstructured":"Tiulpakov M, Ioutsi V, Kalinchenko N, \u0438 \u0434\u0440. Salivary Steroids Quantification by HPLC-MS\/MS:Comparative Evaluation of Sample Collection Methods for Analysis in Patients with Congenital Adrenal Hyperplasia. J Anal Bioanal Tech. 15:667. doi: https:\/\/doi.org\/10.4172\/2155-9872.1000667"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ioutsi VA, Panov YM, Usol\u2019tseva LO, et al. Analysis of Serum Estrogens Using High-Performance Liquid Chromatography\u2013 Tandem Mass Spectrometry Coupled to Differential Ion Mobility Spectrometry. J Anal Chem. 2022;77:1760\u20131766. doi: https:\/\/doi.org\/10.1134\/S1061934822140027","DOI":"10.1134\/S1061934822140027"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Rauh M. Steroid measurement with LC-MS\/MS in pediatric endocrinology. Molecular and cellular endocrinology. 2009; 301(1-2):272-81. doi: https:\/\/doi.org\/10.1016\/j.mce.2008.10.007\/","DOI":"10.1016\/j.mce.2008.10.007"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/13551\/10917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:40:20Z","timestamp":1769686820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/13551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,12,2]]}},"URL":"https:\/\/doi.org\/10.14341\/probl13551","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"value":"2308-1430","type":"electronic"},{"value":"0375-9660","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}